| [1] |
LU Kepeng, LIU Caihong, BI Ying.
Effect of prophylactic anticoagulation duration on venous thrombosis after total hip/knee arthroplasty
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1269-1274.
|
| [2] |
YU Qiaoling, ZHAI Weiwei, LIU Ping, QIU Bo, WU Huizhen.
Research progress in plasma concentration monitoring of rivaroxaban
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 809-817.
|
| [3] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
| [4] |
LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang.
Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273.
|
| [5] |
WANG Tiantian, CAO Junjie, LIU Xuhui, PEI Renzhi, LU Ying.
Clinical analysis of the effect of fludarabine combined with post-transplantation cyclophosphamide in haploid hematopoietic stem cell transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 295-301.
|
| [6] |
.
Research Progress of Pharmacogenomics of Dabigatran Etexilate and Rivaroxaban
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1200-1207.
|
| [7] |
QIN Wenjie, YANG Zhiling, CAO Ailin, GAO Hang, JIANG Xianrui, SHEN Yue, QIAN Jiao.
Advances in the study of new oral anticoagulants in cancer-associated venous thromboembolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 823-828.
|
| [8] |
YANG Bo, SHI Dawei, ZHENG Zaoqian.
Pharmaceutical care on one case of hypobrinogenemia induced by hemocoagulase
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 932-936.
|
| [9] |
ZHANG Ya-tong, LIANG Xin, HU Xin, LI Ke-xin, YANG Li-ping.
Ligase-based method to detect the polymorphism of warfarin related genes: VKORC1,CYP2C9
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1395-1401.
|
| [10] |
LI Hua, CHEN Ling-xia, XU Rui-an.
Pharmaceutical methods of identifying fibrinolytic activity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 1066-1070.
|
| [11] |
TANG Song-shan, WANG Xiao-hua, ZHANG Juan-hui, ZHANG Yuan, LEI Tian-luo, BU Xiu-yun.
Experimental study on hemostatic effects of agacutin, a novel thrombinlike enzyme from Agkistrodon acutus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 781-786.
|
| [12] |
ZHANG Zhe-wen, WEI Hu-lai, SU Hai-xiang, LIU Jian-min, HAO Chun-yan.
Kappa-selenocarrageenan-induced apoptosis of multidrug-resistant human leukemia cell and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 505-508.
|
| [13] |
LI Cong-Zhu, ZHAI Yu-Xia.
Efficacy of domestic rhG-CSF on leucopenia induced by chemotherapy in patients with gynecological tumors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(11): 1301-1304.
|
| [14] |
ZHANG Xiao-Hui, LIANG Feng-Zhen.
Clinical evaluation of the effect of therapy of kidney tonification and blood activation on patients with chronic aplastic anemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 423-425.
|
| [15] |
WEI Qing-Yang, YUE Hui-Fang.
Clinical therapeutic effects oflow molecular weight heparin combined with xiangdan inPatients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 465-467.
|
